| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 5 genes, 4 drugs (DrugBank), 41 diseases shown |
[4] BRAF, FLT3, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2 | Adherens junction 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 3 | Adipocytokine signaling pathway 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 4 | Adrenergic signaling in cardiomyocytes 12 genes, 8 drugs (DrugBank), 30 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] SCN5A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 5 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 15 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 6 | Alcoholism 3 genes, 3 drugs (DrugBank), 4 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| 7 | Aldosterone synthesis and secretion 5 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 8 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] NR3C2 |
D00443 |
Spironolactone |
[6] 58, 67, 86, 113, 218, 225 |
| 9 | Alzheimer disease 9 genes, 3 drugs (DrugBank), 33 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 10 | Amoebiasis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 11 | Amphetamine addiction 7 genes, 3 drugs (DrugBank), 33 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 12 | AMPK signaling pathway 6 genes, 6 drugs (DrugBank), 59 diseases shown |
[1] ADRA1A |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 13 | Amyotrophic lateral sclerosis (ALS) 6 genes, 2 drugs (DrugBank), 30 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 14 | Apelin signaling pathway 5 genes, 4 drugs (DrugBank), 48 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 15 | Apoptosis 5 genes, 3 drugs (DrugBank), 2 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 16 | Arachidonic acid metabolism 2 genes, 2 drugs (DrugBank), 16 diseases shown |
[2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 18 | Autophagy - animal 4 genes, 3 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 19 | Autophagy - other 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 20 | Axon guidance 7 genes, 4 drugs (DrugBank), 38 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 21 | B cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 22 | Base excision repair 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
| 23 | Bile secretion 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 24 | Bladder cancer 4 genes, 3 drugs (DrugBank), 10 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 25 | Breast cancer 8 genes, 8 drugs (DrugBank), 45 diseases shown |
[4] BRAF, FLT4, KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 26 | C-type lectin receptor signaling pathway 7 genes, 4 drugs (DrugBank), 39 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 27 | Calcium signaling pathway 29 genes, 21 drugs (DrugBank), 57 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] AVPR1A |
D01236 |
Conivaptan |
[1] 86 |
| D07748 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [4] CHRM1, CHRM2, CHRM3, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D07171 |
Sitaxentan |
[1] 86 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
| D00669 |
| D02419 |
| D03285 |
| D03360 |
| D03854 |
| [1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] PDGFRB |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
| 28 | cAMP signaling pathway 12 genes, 14 drugs (DrugBank), 31 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [2] CHRM1, CHRM2 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| D07171 |
Sitaxentan |
[1] 86 |
| 29 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 30 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 31 | Cell cycle 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 32 | Cellular senescence 8 genes, 5 drugs (DrugBank), 52 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 33 | Central carbon metabolism in cancer 8 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [5] FLT3, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 34 | cGMP-PKG signaling pathway 26 genes, 18 drugs (DrugBank), 56 diseases shown |
[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D07171 |
Sitaxentan |
[1] 86 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| D10027 |
Udenafil |
[1] 86 |
| D02731 |
Vardenafil |
[3] 13, 86, 299 |
| D03260 |
| D08668 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 35 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
| 36 | Chemical carcinogenesis 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 37 | Chemokine signaling pathway 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 38 | Choline metabolism in cancer 5 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 39 | Cholinergic synapse 9 genes, 3 drugs (DrugBank), 5 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
| 40 | Chronic myeloid leukemia 3 genes, 3 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 41 | Circadian entrainment 5 genes, 3 drugs (DrugBank), 9 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 42 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 43 | Cocaine addiction 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| 44 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| 45 | Colorectal cancer 4 genes, 3 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 46 | Cortisol synthesis and secretion 5 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 47 | Cushing syndrome 7 genes, 5 drugs (DrugBank), 14 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] BRAF |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 48 | Cytokine-cytokine receptor interaction 5 genes, 4 drugs (DrugBank), 26 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
| 49 | Dilated cardiomyopathy (DCM) 5 genes, 5 drugs (DrugBank), 15 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 50 | Dopaminergic synapse 9 genes, 6 drugs (DrugBank), 38 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] DRD2 |
D01348 |
Terguride |
[2] 51, 86 |
| [3] DRD2, DRD3, DRD4 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| [3] PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SCN1A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 51 | Drug metabolism - other enzymes 2 genes, 2 drugs (DrugBank), 12 diseases shown |
[1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 52 | EGFR tyrosine kinase inhibitor resistance 9 genes, 7 drugs (DrugBank), 52 diseases shown |
[4] BRAF, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 53 | Endocrine and other factor-regulated calcium reabsorption 1 gene, 3 drugs (DrugBank), 8 diseases shown |
[1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| 54 | Endocrine resistance 6 genes, 6 drugs (DrugBank), 40 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 55 | Endocytosis 2 genes, 3 drugs (DrugBank), 14 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 56 | Endometrial cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 58 | ErbB signaling pathway 5 genes, 5 drugs (DrugBank), 41 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 59 | Estrogen signaling pathway 5 genes, 6 drugs (DrugBank), 15 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
| D02271 |
| D08233 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 60 | Fc epsilon RI signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 61 | Fc gamma R-mediated phagocytosis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 62 | Fluid shear stress and atherosclerosis 9 genes, 7 drugs (DrugBank), 38 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] KDR |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 63 | Focal adhesion 8 genes, 5 drugs (DrugBank), 16 diseases shown |
[5] BRAF, FLT4, KDR, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 64 | FoxO signaling pathway 5 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 65 | GABAergic synapse 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| 66 | Gap junction 9 genes, 10 drugs (DrugBank), 26 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 67 | Gastric acid secretion 4 genes, 3 drugs (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| [1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
| 68 | Gastric cancer 4 genes, 3 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 69 | Glioma 6 genes, 5 drugs (DrugBank), 41 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 70 | Glucagon signaling pathway 7 genes, 2 drugs (DrugBank), 40 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 71 | Glutamatergic synapse 7 genes, 3 drugs (DrugBank), 33 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 72 | Glutathione metabolism 2 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
| [1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 73 | GnRH secretion 6 genes, 6 drugs (DrugBank), 12 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 74 | GnRH signaling pathway 6 genes, 4 drugs (DrugBank), 8 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 75 | Growth hormone synthesis, secretion and action 6 genes, 4 drugs (DrugBank), 39 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 76 | Hematopoietic cell lineage 7 genes, 7 drugs (DrugBank), 60 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
| [2] FLT3, KIT |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| 77 | Hepatitis B 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 78 | Hepatitis C 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 79 | Hepatocellular carcinoma 5 genes, 4 drugs (DrugBank), 36 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 80 | Herpes simplex virus 1 infection 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 81 | HIF-1 signaling pathway 4 genes, 4 drugs (DrugBank), 48 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 82 | Human cytomegalovirus infection 13 genes, 11 drugs (DrugBank), 72 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 83 | Human immunodeficiency virus 1 infection 7 genes, 3 drugs (DrugBank), 49 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 84 | Human papillomavirus infection 6 genes, 7 drugs (DrugBank), 46 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 85 | Human T-cell leukemia virus 1 infection 7 genes, 2 drugs (DrugBank), 39 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 86 | Huntington disease 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 87 | Hypertrophic cardiomyopathy (HCM) 7 genes, 4 drugs (DrugBank), 21 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 88 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 89 | Inflammatory mediator regulation of TRP channels 3 genes, 3 drugs (DrugBank), 23 diseases shown |
[1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
| D00669 |
| D02419 |
| D03285 |
| D03360 |
| D03854 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
| 90 | Influenza A 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 91 | Insulin resistance 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 92 | Insulin secretion 5 genes, 3 drugs (DrugBank), 5 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
| 93 | Insulin signaling pathway 5 genes, 3 drugs (DrugBank), 46 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 94 | JAK-STAT signaling pathway 7 genes, 7 drugs (DrugBank), 51 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
| 95 | Kaposi sarcoma-associated herpesvirus infection 9 genes, 6 drugs (DrugBank), 57 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 96 | Leishmaniasis 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 97 | Long-term depression 5 genes, 2 drugs (DrugBank), 7 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 98 | Long-term potentiation 8 genes, 4 drugs (DrugBank), 34 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 99 | Longevity regulating pathway 4 genes, 3 drugs (DrugBank), 50 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 100 | Longevity regulating pathway - multiple species 3 genes, 2 drugs (DrugBank), 46 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 101 | MAPK signaling pathway 21 genes, 10 drugs (DrugBank), 53 diseases shown |
[7] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 102 | Melanogenesis 3 genes, 5 drugs (DrugBank), 19 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] KIT |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] KIT, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 103 | Melanoma 5 genes, 4 drugs (DrugBank), 14 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 104 | Metabolic pathways 13 genes, 13 drugs (DrugBank), 49 diseases shown |
[1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
| [2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| [1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| [1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| D10027 |
Udenafil |
[1] 86 |
| D02731 |
Vardenafil |
[3] 13, 86, 299 |
| D03260 |
| D08668 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 105 | MicroRNAs in cancer 8 genes, 8 drugs (DrugBank), 48 diseases shown |
[2] ABL1, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] ABL1, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 106 | Morphine addiction 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
| D02271 |
| D08233 |
| 107 | mTOR signaling pathway 5 genes, 3 drugs (DrugBank), 46 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 108 | Natural killer cell mediated cytotoxicity 7 genes, 2 drugs (DrugBank), 31 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 109 | Necroptosis 3 genes, 1 drug (DrugBank), 1 disease shown |
[3] PARP1, PARP2, PARP3 |
D09730 |
Olaparib |
[1] 86 |
| 110 | Neuroactive ligand-receptor interaction 31 genes, 26 drugs (DrugBank), 70 diseases shown |
[9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [2] AVPR1A, AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
| D07748 |
| [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [3] DRD2, DRD3, DRD4 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| [2] DRD2, PRL |
D01348 |
Terguride |
[2] 51, 86 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D07171 |
Sitaxentan |
[1] 86 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] HRH1 |
D00300 |
Diphenhydramine |
[5] 49, 51, 70, 86, 256 |
| D00669 |
| D02419 |
| D03285 |
| D03360 |
| D03854 |
| [1] HRH2 |
D00318 |
Famotidine |
[3] 6, 46, 86 |
| [1] NR3C1 |
D00407 |
Methylprednisolone |
[36] 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
| D00751 |
| D00979 |
| D05000 |
| D05001 |
| D05002 |
| D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| [1] OPRM1 |
D00842 |
Morphine |
[4] 36, 46, 70, 86 |
| D02271 |
| D08233 |
| [1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
| D00106 |
Epoprostenol |
[1] 86 |
| D01337 |
| D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
| D10725 |
Ralinepag |
[1] 86 |
| D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
| [1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
| [1] TRPV1 |
D00250 |
Capsaicin |
[6] 2, 6, 19, 86, 113, 226 |
| 111 | Neurotrophin signaling pathway 4 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| 112 | NF-kappa B signaling pathway 3 genes, 4 drugs (DrugBank), 29 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] PARP1 |
D09730 |
Olaparib |
[1] 86 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 113 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 3 drugs (DrugBank), 30 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 114 | Non-small cell lung cancer 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 115 | Oocyte meiosis 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[1] AR |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 116 | Osteoclast differentiation 7 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 117 | Ovarian steroidogenesis 2 genes, 3 drugs (DrugBank), 18 diseases shown |
[1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 118 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] ATP4A, ATP4B |
D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| 119 | Oxytocin signaling pathway 17 genes, 9 drugs (DrugBank), 54 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 120 | p53 signaling pathway 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 121 | Pancreatic cancer 5 genes, 4 drugs (DrugBank), 38 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 122 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
| 123 | Parathyroid hormone synthesis, secretion and action 3 genes, 2 drugs (DrugBank), 5 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| 124 | Parkinson disease 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| 125 | Pathogenic Escherichia coli infection 2 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 126 | Pathways in cancer 22 genes, 19 drugs (DrugBank), 72 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [3] AR, ESR1, ESR2 |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| [7] BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D07171 |
Sitaxentan |
[1] 86 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 127 | PD-L1 expression and PD-1 checkpoint pathway in cancer 8 genes, 4 drugs (DrugBank), 49 diseases shown |
[1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 128 | Phospholipase D signaling pathway 9 genes, 7 drugs (DrugBank), 43 diseases shown |
[1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [2] AVPR1A, AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
| D07748 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [3] KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 129 | PI3K-Akt signaling pathway 16 genes, 10 drugs (DrugBank), 61 diseases shown |
[2] CHRM1, CHRM2 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 130 | Platelet activation 7 genes, 11 drugs (DrugBank), 21 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] P2RY12 |
D00769 |
Clopidogrel |
[2] 49, 86 |
| D07729 |
| D10823 |
| D10824 |
| [1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
| D00106 |
Epoprostenol |
[1] 86 |
| D01337 |
| D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
| D10725 |
Ralinepag |
[1] 86 |
| D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
| [1] PTGS1 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] TBXA2R |
D04500 |
Ifetroban |
[3] 51, 86, 113 |
| 131 | Platinum drug resistance 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| 132 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 133 | Progesterone-mediated oocyte maturation 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 134 | Prolactin signaling pathway 4 genes, 5 drugs (DrugBank), 10 diseases shown |
[2] ESR1, ESR2 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] PRL |
D01348 |
Terguride |
[2] 51, 86 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 135 | Prostate cancer 8 genes, 7 drugs (DrugBank), 54 diseases shown |
[1] AR |
D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| [3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 136 | Protein processing in endoplasmic reticulum 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| 137 | Proteoglycans in cancer 7 genes, 7 drugs (DrugBank), 41 diseases shown |
[3] BRAF, KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 138 | Purine metabolism 6 genes, 7 drugs (DrugBank), 28 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] HPRT1 |
D00161 |
Mercaptopurine |
[5] 86, 94, 96, 97, 164 |
| D04931 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| D10027 |
Udenafil |
[1] 86 |
| D02731 |
Vardenafil |
[3] 13, 86, 299 |
| D03260 |
| D08668 |
| [1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 139 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank), 8 diseases shown |
[1] RRM2 |
D00341 |
Hydroxyurea |
[8] 3, 13, 19, 20, 65, 85, 86, 284 |
| 140 | Rap1 signaling pathway 10 genes, 7 drugs (DrugBank), 16 diseases shown |
[6] BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] DRD2 |
D01462 |
Lisuride |
[2] 6, 86 |
| D08132 |
| D01348 |
Terguride |
[2] 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [2] KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [3] KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 141 | Ras signaling pathway 10 genes, 5 drugs (DrugBank), 16 diseases shown |
[3] ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [4] ABL1, KIT, PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 142 | Regulation of actin cytoskeleton 10 genes, 5 drugs (DrugBank), 14 diseases shown |
[3] BRAF, PDGFRB, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] PDGFRA |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| [2] PDGFRA, PDGFRB |
D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 143 | Regulation of lipolysis in adipocytes 5 genes, 6 drugs (DrugBank), 27 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [3] ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 144 | Relaxin signaling pathway 4 genes, 5 drugs (DrugBank), 16 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 145 | Renal cell carcinoma 3 genes, 2 drugs (DrugBank), 9 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 146 | Renin secretion 18 genes, 14 drugs (DrugBank), 51 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [2] ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [3] ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| D07171 |
Sitaxentan |
[1] 86 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 147 | Renin-angiotensin system 4 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] ACE |
D00251 |
Captopril |
[2] 17, 86 |
| [2] AGTR1, AGTR2 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] ANPEP |
D00087 |
Ubenimex |
[1] 86 |
| 148 | Retrograde endocannabinoid signaling 5 genes, 4 drugs (DrugBank), 18 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 149 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 150 | Salivary secretion 10 genes, 6 drugs (DrugBank), 24 diseases shown |
[5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| [6] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] ADRB2 |
D02147 |
Salbutamol |
[13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
| [1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 151 | Serotonergic synapse 9 genes, 6 drugs (DrugBank), 22 diseases shown |
[2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [2] PTGS1, PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] SLC6A4 |
D00326 |
Fluoxetine |
[6] 13, 17, 78, 86, 179, 206 |
| D00823 |
| 152 | Shigellosis 4 genes, 5 drugs (DrugBank), 51 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| [1] EGFR |
D03455 |
Cetuximab |
[5] 34, 51, 86, 89, 331 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 153 | Signaling pathways regulating pluripotency of stem cells 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 154 | Small cell lung cancer 1 gene, 2 drugs (DrugBank), 16 diseases shown |
[1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 155 | Sphingolipid signaling pathway 2 genes, 2 drugs (DrugBank), 2 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 156 | Steroid hormone biosynthesis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] CYP19A1 |
D00960 |
Anastrozole |
[3] 78, 86, 193 |
| 157 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] SLC6A4 |
D00326 |
Fluoxetine |
[6] 13, 17, 78, 86, 179, 206 |
| D00823 |
| 158 | T cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 159 | Taste transduction 5 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] CHRM3 |
D02212 |
Ipratropium |
[2] 6, 86 |
| [3] SCN2A, SCN3A, SCN9A |
D00358 |
Lidocaine |
[10] 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| 160 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 19 diseases shown |
[1] HMGCR |
D00434 |
Simvastatin |
[19] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 161 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ACVR2A |
D09670 |
Sotatercept |
[2] 86, 284 |
| 162 | Th1 and Th2 cell differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 163 | Th17 cell differentiation 8 genes, 4 drugs (DrugBank), 62 diseases shown |
[1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 164 | Thermogenesis 6 genes, 5 drugs (DrugBank), 53 diseases shown |
[1] ADRB3 |
D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 165 | Thyroid cancer 3 genes, 2 drugs (DrugBank), 18 diseases shown |
[2] BRAF, RET |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 166 | Thyroid hormone signaling pathway 3 genes, 5 drugs (DrugBank), 40 diseases shown |
[1] ESR1 |
D01161 |
Fulvestrant |
[1] 86 |
| D08409 |
Prasterone |
[6] 49, 53, 83, 86, 96, 113 |
| D00966 |
Tamoxifen |
[4] 2, 86, 113, 227 |
| D08559 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 167 | Tight junction 4 genes, 4 drugs (DrugBank), 20 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 168 | TNF signaling pathway 2 genes, 3 drugs (DrugBank), 16 diseases shown |
[1] MAP3K5 |
D10988 |
Selonsertib |
[1] 86 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| 169 | Transcriptional misregulation in cancer 3 genes, 3 drugs (DrugBank), 27 diseases shown |
[1] FLT3 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 170 | Tuberculosis 6 genes, 2 drugs (DrugBank), 31 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| 171 | Type II diabetes mellitus 3 genes, 3 drugs (DrugBank), 39 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 172 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] KEAP1 |
D03846 |
Dimethyl fumarate |
[5] 13, 46, 49, 51, 86 |
| 173 | Vascular smooth muscle contraction 16 genes, 18 drugs (DrugBank), 30 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00255 |
Carvedilol |
[4] 6, 57, 86, 113 |
| D03415 |
| D00095 |
Epinephrine |
[9] 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| [1] AGTR1 |
D00150 |
Angiotensin II |
[7] 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| [1] AVPR1A |
D01236 |
Conivaptan |
[1] 86 |
| D07748 |
| [2] BRAF, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D00617 |
Nicardipine |
[2] 70, 86 |
| D08270 |
| [1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| D07171 |
Sitaxentan |
[1] 86 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PTGIR |
D02720 |
Beraprost |
[1] 86 |
| D00106 |
Epoprostenol |
[1] 86 |
| D01337 |
| D02721 |
Iloprost |
[4] 51, 84, 85, 86 |
| D10725 |
Ralinepag |
[1] 86 |
| D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
| 174 | Vasopressin-regulated water reabsorption 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AVPR2 |
D01236 |
Conivaptan |
[1] 86 |
| D07748 |
| 175 | VEGF signaling pathway 9 genes, 5 drugs (DrugBank), 44 diseases shown |
[2] KDR, RAF1 |
D06272 |
Sorafenib |
[2] 34, 86 |
| D08524 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] PTGS2 |
D00217 |
Acetaminophen |
[13] 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| [1] VEGFA |
D06409 |
Bevacizumab |
[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 |
| 176 | Viral myocarditis 1 gene, 2 drugs (DrugBank), 13 diseases shown |
[1] ABL1 |
D01441 |
Imatinib |
[11] 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D08953 |
Nilotinib |
[5] 6, 8, 34, 51, 86 |
| 177 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank), 16 diseases shown |
[1] IL6R |
D02596 |
Tocilizumab |
[16] 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 178 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |